CRMD - CorMedix Inc.
6.72
0.160 2.381%
Share volume: 1,820,853
Last Updated: 03-10-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.17%
PREVIOUS CLOSE
CHG
CHG%
$6.56
0.16
0.02%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-14-2024 | 10-30-2024 | 03-25-2025 | 05-06-2025 | 08-07-2025 | 11-12-2025 | 03-05-2026 | |
| Assets | |||||||||
| Total Assets | 68.024 M | 57.731 M | 77.586 M | 118.846 M | 149.583 M | 252.599 M | 750.861 M | 826.142 M | |
| Current Assets | 63.410 M | 53.194 M | 73.154 M | 114.575 M | 144.862 M | 248.057 M | 259.535 M | 367.051 M | |
| Inventories | 2.320 M | 4.012 M | 6.649 M | 7.600 M | 7.488 M | 9.634 M | 28.917 M | 29.716 M | |
| Other Current Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Short Term Investments | 23.371 M | 17.070 M | 10.744 M | 11.037 M | 11.217 M | 31.403 M | 7.224 M | 3.694 M | |
| Total Receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 35.181 M | 28.541 M | 35.286 M | 40.651 M | 66.286 M | 159.309 M | 48.493 M | 144.837 M | |
| Total Non-current Assets | 103.838 K | 104.426 K | 105.084 K | 105.368 K | 105.084 K | 105.084 K | 22.914 M | 23.816 M | |
| Property Plant Equipment | 1.906 M | 1.916 M | 1.900 M | 1.828 M | 1.728 M | 1.641 M | 7.521 M | 5.959 M | |
| Other Assets | 2.708 M | 2.621 M | 2.532 M | 2.442 M | 2.993 M | 2.901 M | 483.805 M | 453.132 M | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 68.024 M | 57.731 M | 77.586 M | 118.846 M | 149.583 M | 252.599 M | 750.861 M | 826.142 M | |
| Total liabilities | 10.011 M | 11.547 M | 18.874 M | 34.189 M | 34.695 M | 31.969 M | 376.732 M | 420.835 M | |
| Total current liabilities | 9.534 M | 11.111 M | 18.481 M | 33.840 M | 34.391 M | 31.711 M | 133.644 M | 174.269 M | |
| Accounts Payable | 2.826 M | 3.345 M | 1.344 M | 1.720 M | 1.933 M | 5.815 M | 20.454 M | 7.884 M | |
| Other liabilities | 0.000 | 435.246 K | 392.967 K | 349.091 K | 304.092 K | 258.073 K | 95.591 M | 101.354 M | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 0.000 | 435.246 K | 392.967 K | 349.091 K | 304.092 K | 258.073 K | 95.591 M | 101.354 M | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 58.013 M | 46.184 M | 58.712 M | 84.657 M | 114.888 M | 220.630 M | 374.129 M | 405.307 M | |
| Common stock | 394.095 M | 396.416 M | 411.717 M | 424.196 M | 433.790 M | 519.709 M | 564.637 M | 581.879 M | |
| Retained earnings | -336.166 M | -350.318 M | -353.094 M | -339.630 M | -318.986 M | -299.158 M | -190.595 M | -176.575 M |